
Wholesale pricing available for approved accounts
Thymosin Beta-4 fragment — a 43 amino acid synthetic peptide identical to the endogenous protein. Extensively researched for its role in cell migration, tissue repair, and angiogenesis studies.
All Signal peptides undergo rigorous third-party testing and are guaranteed ≥99% purity. Every batch comes with a Certificate of Analysis (COA) verified through AuthentiChain's blockchain verification system.
Orders placed before 12PM EST ship same-day via cold chain logistics. Products are shipped in insulated packaging with dry ice to maintain temperature integrity. Standard delivery is 1–3 business days.
Approved accounts have access to flexible payment terms including NET 30, wire transfer, and credit card. Volume-based pricing is automatically applied at checkout based on your order quantity.
Absolutely. Contact your dedicated account manager or reach out to info@signalpeps.com with the product name and lot number. COAs are also available digitally through our AuthentiChain verification badge on each product page.
In-depth findings from peer-reviewed preclinical and clinical studies
TB-500 is a synthetic peptide representing the active region of Thymosin Beta-4, a 43-amino acid protein involved in cell migration, tissue repair, and angiogenesis throughout the body.
Thymosin Beta-4 promoted re-epithelialization, cell migration, wound contraction, and collagen deposition in dermal and corneal wound models, including impaired healing contexts such as diabetic and aged mice.
Annals of the New York Academy of Sciences (2010)Thymosin Beta-4 decreased myofibroblast presence in wound models, leading to reduced scar formation and fibrosis while maintaining effective tissue repair.
Annals of the New York Academy of Sciences (2010)TB-500 promoted new blood vessel formation by increasing VEGF expression and mobilizing stem/progenitor cells through its actin-binding properties, facilitating tissue regeneration.
Nature (2004)Thymosin Beta-4 reduced inflammation by downregulating NF-κB and decreasing levels of various inflammatory cytokines across brain, liver, eye, and heart disease models.
Expert Opinion on Biological Therapy (2020)In chronic myocardial ischemia models, TB-500 reduced infarct size and improved contractile performance through anti-apoptotic (acute) and progenitor cell activation (chronic) mechanisms, promoting neovascularization.
Expert Opinion on Biological Therapy (2020)TB-500 promoted neurogenesis and angiogenesis while reducing brain lesion volume in traumatic brain injury models. In autoimmune encephalomyelitis models, it stimulated oligodendrogenesis and reduced inflammatory infiltrates.
Expert Opinion on Biological Therapy (2020)Phase I safety studies in healthy volunteers indicated Thymosin Beta-4 was well-tolerated without dose-limiting toxicities. A Phase II trial in severe dry eye showed both safety and symptom improvement.
Expert Opinion on Biological Therapy (2020)All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Three simple steps to access premium research peptides
Submit a quick application with your business details. Takes less than 2 minutes.
Our team reviews applications within 1–2 business days. You'll receive an email once approved.
Browse the catalog, select quantities, and checkout. Volume pricing applies automatically.
All products are for research and laboratory purposes only. Not intended for human or animal consumption. Only qualified professionals should handle these products.